Results 91 to 100 of about 6,372 (199)

Final parameter estimates describing piperaquine population pharmacokinetics.

open access: yes, 2017
Final parameter estimates describing piperaquine population pharmacokinetics.
Michael D. Edstein (1846186)   +23 more
core   +1 more source

The effect of dosing regimens on the antimalarial efficacy of dihydroartemisinin-piperaquine: a pooled analysis of individual patient data.

open access: yesPLoS Medicine, 2013
BackgroundDihydroartemisinin-piperaquine (DP) is increasingly recommended for antimalarial treatment in many endemic countries; however, concerns have been raised over its potential under dosing in young children.
WorldWide Antimalarial Resistance Network (WWARN) DP Study Group
doaj   +1 more source

Artenimol–piperaquine in children with uncomplicated imported falciparum malaria: experience from a prospective cohort

open access: yesMalaria Journal, 2019
Background Although malaria remains one of the major public health threats in inter-tropical areas, there is limited understanding of imported malaria in children by paediatricians and emergency practitioners in non-endemic countries, often resulting in ...
Lauren Pull   +6 more
doaj   +1 more source

A surrogate marker of piperaquine-resistant Plasmodium falciparum malaria: a phenotype–genotype association study [PDF]

open access: yes, 2016
International audienceBACKGROUND:Western Cambodia is the epicentre of Plasmodium falciparum multidrug resistance and is facing high rates of dihydroartemisinin-piperaquine treatment failures.
Ke, Sopheakvatey   +27 more
core   +1 more source

A randomized open study to assess the efficacy and tolerability of dihydroartemisinin-piperaquine for the treatment of uncomplicated falciparum malaria in Cambodia. [PDF]

open access: yes, 2007
OBJECTIVES: To compare the efficacy and tolerability of dihydroartemisinin-piperaquine (DHA-PQP) with that of a 3-day regimen of mefloquine and artesunate (MAS3) for the treatment of uncomplicated falciparum malaria in Cambodia.
D. Socheat   +28 more
core   +1 more source

High therapeutic efficacy of artemether–lumefantrine and dihydroartemisinin–piperaquine for the treatment of uncomplicated falciparum malaria in Somalia

open access: yesMalaria Journal, 2019
Background Artemether–lumefantrine (AL) and dihydroartemisinin–piperaquine (DHA/PPQ) are the recommended first- and second-line treatments, respectively, for uncomplicated falciparum malaria in Somalia.
Marian Warsame   +14 more
doaj   +1 more source

Malaria diagnosis under field conditions in the Venezuelan Amazon.

open access: yes, 2008
To improve practical, accurate diagnosis of malaria in the Amazon rainforest of Venezuela, two rapid diagnostic tests (RDT) (OptiMAL-IT) and FalciVax) and a laboratory light microscope, used in the field with a battery-operated head lamp as an external ...
Fanello, C. I.   +15 more
core   +1 more source

Decreased dihydroartemisinin-piperaquine protection against recurrent malaria associated with Plasmodium falciparum plasmepsin 3 copy number variation in Africa

open access: yesNature Communications
Dihydroartemisinin-piperaquine (DHA-PPQ) is being recommended in Africa for the management of uncomplicated Plasmodium falciparum malaria and for chemoprevention strategies, based on the ability of piperaquine to delay re-infections. Although therapeutic
Leyre Pernaute-Lau   +19 more
doaj   +1 more source

Therapeutic Efficacy and Safety of Dihydroartemisinin-Piperaquine (DP) for the Treatment of Uncomplicated Plasmodium Vivax Malaria: A Single Center Study

open access: yesJLUMHS, 2017
BACKGROUND: Ninety-five millions of Pakistan's 161 million people, roughly 60% of Pakistan’s population live in malaria endemic regions. Despite a well-established malaria control programme, 500,000 malaria infections and 50,000 malaria-attributable ...
Salma Shaikh   +5 more
doaj   +1 more source

Rethinking Dosing Regimen Selection of Piperaquine for Malaria Chemoprevention: A Simulation Study.

open access: yesPLoS ONE, 2016
BackgroundThe combination of short-acting dihydroartemisinin and long-acting piperaquine (DP) is among the first-line therapies for the treatment of uncomplicated Plasmodium falciparum malaria.
Nancy C Sambol   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy